fbpx

Financials

Overview

MDxHealth operates on a calendar basis with its accounting year ending on Dec. 31. The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. MDxHealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3.

Furthermore, for the Annual General Shareholders’ Meeting, the company also publishes the non-consolidated Belgian-GAAP financial statements of the parent company. Prior to October 5, 2010, MDxHealth operated under the name OncoMethylome Sciences

2021 Reporting Calendar

  • March 3, 2021: Publication of FY2020 results
  • April 21, 2021: Q1-2021 business update
  • May 27, 2021: Annual general shareholders’ meeting
  • August 26, 2021: Publication of H1-2021 results
  • October 21, 2021: Q3-2021 business update

3-year Snapshot

In “000” of USD

Profit & Loss202020192018
Revenues18,46011,78528,397
Gross Profit8,0443016,745
Research & Development Expenses-4.543-8,897-4,280
Selling & Marketing Expenses-16,752-17,809-29,591(1)
General & Administrative Expenses-13,990-15,196(1)-15,207(1)
Other Operating (Expense)/Income118-197235
Operating Loss-27,123-43,169-32,098
Financial Expense, Net-1,539-506-393
Loss Before Income Tax-28,662-43,675-32.491
Income Tax057441
Loss for the Year-28,662-43,100-32,450

(1) The comparative figures for 2018 have been reclassed to reflect the breakdown of Selling, General and Administrative Expenses into General and Administrative Expenses and Selling and Marketing Expenses.  (2) 2017 figures are the aggregate of Selling, General and Administrative Expenses.

Assests

202020192018
Total Non-Current Assets8,7659,72117,613
Total Current Assets23,09130,90747,863
Of Which Cash & Cash Equivalents15,95322,05026,203
Total Assets31,85640,62865,476

Liabilities and Shareholders’ Equity

202020192018
Total Equity5,84919,72452,117
Non-Current Liabilities12,98610,4771,882
Current Liabilities13,02110,42711,477
Total Equity & Liabilities31,85640,62865,476

Cash Flows

202020192018
Operating Cash Flow-20,131-22,289-28,543
Investing Cash Flow-537-73-1,345
Financing Cash Flow14,95417,96541,672
Cash & Cash Equivalents at End of Period15,95322,05026,203

Financial Reports

2021

2021 Interim Report: English I Français

2020

2020 Interim Report: EnglishFrançais

2020 Consolidated Figures: English

2020 Board Report on Financial Statements: English I Français

2020 Full Non-consolidated Statutory Accounts: Français

2020 Annual Report: English I Français

2020 Auditor Opinion: English I  Français

2019

2019 Interim Report: English | Français

2019 Consolidated Figures: English

2019 Board Report on Financial Statements: English I Français

2019 Full Non-consolidated Statutory Accounts: Français

2019 Annual Report: English I Français

2019 Auditor Opinion: English I Français

 

 

2018

2018 Interim Report: English | Français

2018 Consolidated Figures: English

2018 Board Report: English 

2018 Full non consolidated statutory Accounts: Français

2018 Annual Report: English | Français

2018 Auditor Opinion: English | Français

2017

2017 Annual Report “after correction to take into account a clerical drafting error”: english | français

Full year 2017 Non Consolidated Statutory Account: français

Auditors Opinion: english | français

Board Report on 2017 Financial Statements “after correction to take into account a clerical drafting error”: english | français

2017 Consolidated figures: english

2017 Interim report: english | français

2016

2016 Annual Report: english | français

Full year 2016 Non Consolidated Statutory Account : français

Auditors Opinion: english

Board Report on 2016 Financial Statements: english | français

2016 Interim report : english | français

2016 Consolidated figures: english

2015

2015 Interim report : english | français

2015 Consolidated Statement of Comprehensive Income: english

2015 Annual Report : english | français

Full Year 2015 Non Consolidated Statutory Accounts: français

Auditors Opinion: english | français

2014

Full Annual Report: english | français

2014 Consolidated Statements: english

Full Year 2014 Non Consolidated Statutory Accounts: français

Auditors Opinion: english | français

2014 Interim Report: english | français

2013

2013 Interim Report: english | français

Full Annual Report: english | français

New full year 2013 non-consolidated statement account: français

Auditor’s opinion: english | français

Full year 2013 non-consolidated statutory accounts: français

Consolidated Financial Statements 2013: english

2012

Full year 2012 Registration Document (Annual Report): English | Français

2012 Auditor’s opinion: English | Français

Full year 2012 non-consolidated statutory accounts: Français

2012 Interim Report: English | Français

Consolidated Financial Statements 2012: English

2011

Full year 2011 Registration Document (Annual report): English | Français

2011 Auditor’s Opinion: English | Français

Full year 2011 non-consolidated statutory accounts and reports: Français

2011 Interim Report: English | Français

2011 Full Year Results Financial Report: English

2010

2010 Auditor’s Opinion: English | Français

Full year 2010 non-consolidated statutory accounts and reports: Français

2010 Full Year Results Financial Report: English

2010 Interim Report: English | Français

2009

Full year 2009 non-consolidated statutory accounts and reports: Français

2009 Full Year Results Financial Report: English

2009 Interim Report: English | Français

Full year 2009 Registration Document (Annual report): English | Français

2008

2008 Annual Brochure: English | Français

2008 Registration Document: English | Français

2008 Full Year Results Financial Report: English

2008 Interim Report: English | Français

2007

Full year 2007 Registration Document (Annual Report): English | Français

2007 Full Year Results: English | Français

2007 Full Year Results Financial Report: English

2007 Half Year Results: English | Français

2007 Half Year Results Financial Report: English

2006 Annual Brochure: English | Français

2006

Statutory Statements with Reports of Board and Auditor: English

2006 Half year Report (June 30 figures): Français

Full year 2006 Registration Document (Annual Report): English | Français

2006 Full Year Results: English | Français

2006 Full Year Results Financial Report: English

SEC Filings

Special Reports

The financial service for the shares of the company is provided in Belgium by ING. Shareholders should inform themselves about the costs that other financial intermediaries may charge in connection with paying agency services.

Special Reports of the Board and Auditor

Board Report in relation to the capital increase of 8 November 2021 (ENG)

Board Report in relation to the capital increase of 8 November 2021 (FR)

Auditor Report in relation to the capital increase of 8 November 021 – contribution in kind (FR)

Auditor Report in relation to the capital increase of 8 November 2021 (FR)

Board Report in relation to the capital increase of 26 January 2021 (FR)

Board Report in relation to the capital increase of 26 January 2021 (EN)

Auditor Report in relation to the capital increase of 26 January 2021 (FR)

Report of the Statutory Auditor in relation to the equity investment by MVM, dated May 15, 2020 (EN)

Report of the Statutory Auditor in relation to the equity investment by MVM, dated May 15, 2020 (FR)

Board Report in relation to the equity investment by MVM, dated May 15, 2020 (EN)

Board Report in relation to the equity investment by MVM, dated May 15, 2020 (FR)

Auditor Report I art 596

Auditor Report II art 596

2019-09-Auditors Report art 596

2019-09-EN-Board Report art 596

2019-09-FR-Board Report art 596

2018-03-Auditors Report art 596

2018-03-EN-Board Report art 596

2018-03-FR-Board Report art 596

006 Board Report 596 (FR)[5].pdf

604 Board Report (FR) exec.pdf

604 Board Report (FR).pdf

583 596 598 Board Report and Plan (EN).pdf

583 596 598 Board Report and Plan (FR).pdf

R Mdx art 596-598 Plan d’options sur Action May 2017 – 2.500.000 SOP.pdf

Rapport special du conseil dadministration.article596.Nov_.2016.EN_.pdf

Rapport special du conseil dadministration.article596.Nov_.2016.EN_.pdf(FR).pdf

Rapport du commissaire, article 596, 31 octobre 2006 .pdf

Rapport du conseil d’administration. article 604 avril 2016.pdf

604 Board Report (FR) exec.pdf

Rapport du Commissaire, article 602, 18 septembre 2015.pdf

Rapport du Conseil d’Administration, article 602, 18 septembre 2015.pdf

Report of the Board, article 602, September 18, 2015.pdf

Rapport du commissaire – article 596, 23 juin 2015.pdf

Rapport du conseil d’administration, 23 juin 2015.pdf

Rapport du conseil d’administration, 4 novembre 2014.pdf

Rapport du conseil d’administration – articles 583-596-598 – 30 avril 2014.pdf

Rapport du commissaire – articles 596-598 – 30 avril 2014.pdf

Rapport du commissaire, articles 596 et 598, 24 juin 2013.pdf

Rapport du conseil d’administration, 24 juin 2013.pdf

Rapport du conseil d’administration, article 604, 30 avril 2013.pdf

Rapport du commissaire, articles 596 et 598, 28 juin 2012.pdf

Rapport du conseil d’administration, articles 603 juncto 596 et 598, 28 juin 2012.pdf

Rapport du conseil d’administration, articles 583:596:598, 18 avril 2012.pdf

Rapport du commissaire, articles 596:598, 19 avril 2012.pdf

Rapport du conseil d’administration, articles 583:596:598, 27 mai 2011.pdf

Rapport du commissaire, article 596, 27 mai 2011.pdf

Rapport du commissaire, article 596, 4 avril 2011.pdf

Rapport du conseil d’administration, article 603 juncto l’article 596, 4 avril 2011.pdf

Rapport du commissaire, Art. 582:596:598, 10 mai 2010.pdf

Rapport du conseil d’administration, articles 582:583:596:598, 21 juin 2010.pdf

Rapport du conseil d’administration, article 633, 10 mars 2010.pdf

Rapport du commissaire, article 596, 27 janvier 2009.pdf

Rapport du conseil d’administration, articles 583:596, 27 janvier 2009.pdf

Rapport du commissaire, article 596, 15 décembre 2008.pdf

Rapport du conseil d’administration, articles 603:596:589, 15 décembre 2008.pdf

Rapport du conseil d’administration, articles 583:596:589, 30 mai 2008 .pdf

Rapport du commissaire, article 596, 26 mai 2008.pdf

Rapport du conseil d’administration, articles 604, 27 mars 2008.pdf

Rapport du conseil d’administration, articles 603:596, 15 octobre 2007.pdf

Rapport du commissaire, article 596, 15 octobre 2007 .pdf

Rapport du conseil d’administration, articles 583:596:598, 25 mai 2007 .pdf

Rapport du commissaire, articles 596:598, 21 mai 2007 .pdf

Rapport du conseil d’administration, articles 583:596, 18 avril 2007.pdf

Rapport du commissaire, article 596, 16 avril 2007 .pdf

Rapport du conseil d’administration, articles 583:596, 8 november 2006.pdf

Listing prospectus - April 2021

2020 Interim Report English I Français

2019 Annual Report English I Français

2021 Board Report English I Français

2021 Auditor report in relation to the capital increase of 26 January Français

2020 FY Unauditied Consolidated Financial Statements English

2021 Prospectus English I Français

Listing prospectus - October 2020

2019 Annual Report English I Français

2020 H1 Interim Report English I Français

2020 Board Report English I Français

2020 Report on Statutory Auditor in relation to the equity investment by MVM English I Français

2020 Prospectus English I French

Investor Relations Contact

For all investor related questions please call or email:

LifeSci Advisor (PR & IR)

US: +1 949 271 9223
ir@mdxhealth.com